Disparities exist across many cancer types, but they are particularly prevalent in patients with prostate cancer, explained Maggie A. Smith, DNP, MSN/Ed, RN, OCN, field medical director in GU Oncology at Pfizer, and Oncology Nursing News contributor.
African American men have some of the highest incidences and mortality rates from prostate cancer. To address this, oncology nurses can push for more inclusion in clinical trials, and educate their African American patients on the disease and prevention.
Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes vs Chemo in Urothelial Cancer
April 20th 2024Patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin plus pembrolizumab experienced a reduction in the risk for disease progression or death vs chemotherapy.
Maintenance Avelumab Has Similar Efficacy in Real World for Urothelial Cancer
March 5th 2024Patients with metastatic urothelial cancer treated with frontline maintenance therapy with avelumab following platinum-based chemotherapy in the real-world setting had similar outcomes as observed in the JAVELIN Bladder 100 trial.